[go: up one dir, main page]

BRPI0811948B8 - novo agente para a liberação de princípios ativos em curativos que contenham ao menos uma susbtância gordurosa - Google Patents

novo agente para a liberação de princípios ativos em curativos que contenham ao menos uma susbtância gordurosa

Info

Publication number
BRPI0811948B8
BRPI0811948B8 BRPI0811948A BRPI0811948A BRPI0811948B8 BR PI0811948 B8 BRPI0811948 B8 BR PI0811948B8 BR PI0811948 A BRPI0811948 A BR PI0811948A BR PI0811948 A BRPI0811948 A BR PI0811948A BR PI0811948 B8 BRPI0811948 B8 BR PI0811948B8
Authority
BR
Brazil
Prior art keywords
dressings
release
contain
fatty substance
active principles
Prior art date
Application number
BRPI0811948A
Other languages
English (en)
Inventor
Laurensou Christelle
Original Assignee
Urgo Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urgo Lab filed Critical Urgo Lab
Publication of BRPI0811948A2 publication Critical patent/BRPI0811948A2/pt
Publication of BRPI0811948B1 publication Critical patent/BRPI0811948B1/pt
Publication of BRPI0811948B8 publication Critical patent/BRPI0811948B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)

Abstract

novo agente para a liberação de princípios ativos em curativos que contenham ao menos uma substância gordurosa. a presente invenção se refere ao uso, como um agente para a liberação de uma substância ativa em uma composição para um curativo, de um copolímero de um sal de ácido 2-metil-2-[(1-0x0-2- propenil)amino]-1 propanossulfônico e de éster 2-hidroxietil de ácido propanóico. ela também se refere a curativos do tipo que compreendem ao menos uma substância gordurosa e/ou uma matriz elastomérica e ao menos uma substância ativa, que incorpora o referido copolímero.
BRPI0811948A 2007-05-25 2008-05-23 novo agente para a liberação de princípios ativos em curativos que contenham ao menos uma susbtância gordurosa BRPI0811948B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0755272A FR2916356B1 (fr) 2007-05-25 2007-05-25 Nouvel agent permettant le relargage d'actifs dans des pansements contenant au moins un corps gras
PCT/FR2008/050893 WO2008149036A1 (fr) 2007-05-25 2008-05-23 Nouvel agent permettant le relargage d'actifs dans des pansements contenant au moins un corps gras

Publications (3)

Publication Number Publication Date
BRPI0811948A2 BRPI0811948A2 (pt) 2014-10-14
BRPI0811948B1 BRPI0811948B1 (pt) 2018-07-17
BRPI0811948B8 true BRPI0811948B8 (pt) 2021-06-22

Family

ID=38834511

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0811948A BRPI0811948B8 (pt) 2007-05-25 2008-05-23 novo agente para a liberação de princípios ativos em curativos que contenham ao menos uma susbtância gordurosa

Country Status (18)

Country Link
US (1) US10500301B2 (pt)
EP (1) EP2148703B1 (pt)
JP (1) JP5290277B2 (pt)
KR (1) KR101445900B1 (pt)
CN (1) CN101678146B (pt)
AT (1) ATE482726T1 (pt)
AU (1) AU2008259661B2 (pt)
BR (1) BRPI0811948B8 (pt)
CA (1) CA2687731C (pt)
DE (1) DE602008002835D1 (pt)
DK (1) DK2148703T3 (pt)
ES (1) ES2353851T3 (pt)
FR (1) FR2916356B1 (pt)
MX (1) MX2009012743A (pt)
PL (1) PL2148703T3 (pt)
PT (1) PT2148703E (pt)
RU (1) RU2448737C2 (pt)
WO (1) WO2008149036A1 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2916355B1 (fr) * 2007-05-25 2009-08-28 Urgo Soc Par Actions Simplifie Nouveau principe actif dans la cicatrisation et son utilisation
GB0808376D0 (en) 2008-05-08 2008-06-18 Bristol Myers Squibb Co Wound dressing
GB0817796D0 (en) 2008-09-29 2008-11-05 Convatec Inc wound dressing
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
CA2819475C (en) 2010-12-08 2019-02-12 Convatec Technologies Inc. Integrated system for assessing wound exudates
WO2012078723A1 (en) 2010-12-08 2012-06-14 Convatec Technologies Inc. Method and system for removing exudates from a wound site
US9526816B2 (en) 2010-12-08 2016-12-27 Convatec Technologies Inc. Wound exudate monitor accessory
FR2973223B1 (fr) * 2011-03-31 2013-04-19 Urgo Lab Pansement absorbant cicatrisant, ses utilisations pour les plaies chroniques
DK2524705T3 (da) * 2011-05-19 2014-05-12 Lohmann & Rauscher Gmbh & Co Steril sårforbinding med en syntetisk treblokelastomer og et hydrofobt polymert biguanid
ES2489890T3 (es) 2011-05-19 2014-09-02 Lohmann & Rauscher Gmbh & Co. Kg Apósito esterilizado para heridas que comprende un elastómero tribloque sintético
GB201115182D0 (en) 2011-09-02 2011-10-19 Trio Healthcare Ltd Skin contact material
GB2497406A (en) 2011-11-29 2013-06-12 Webtec Converting Llc Dressing with a perforated binder layer
GB201120693D0 (en) 2011-12-01 2012-01-11 Convatec Technologies Inc Wound dressing for use in vacuum therapy
FR2993182B1 (fr) * 2012-07-13 2014-10-17 Urgo Lab Pansement a liberation prolongee d'actifs
CA2895896A1 (en) 2012-12-20 2014-06-26 Convatec Technologies Inc. Processing of chemically modified cellulosic fibres
FR3037788B1 (fr) * 2015-06-29 2022-01-21 Urgo Lab Nouveau pansement absorbant antimicrobien
GB2543544A (en) 2015-10-21 2017-04-26 Brightwake Ltd Wound dressing
EP3435941B1 (en) 2016-03-30 2021-09-01 ConvaTec Technologies Inc. Detecting microbial infections in wounds
KR20190015210A (ko) 2016-03-30 2019-02-13 퀄리자임 다이아그노스틱스 게엠베하 엔드 코 카게 상처에서 미생물 감염의 검출
GB201608099D0 (en) 2016-05-09 2016-06-22 Convatec Technologies Inc Negative pressure wound dressing
CN109640904A (zh) 2016-07-08 2019-04-16 康沃特克科技公司 流体收集设备
PL3481360T3 (pl) 2016-07-08 2022-05-02 Convatec Technologies Inc. Wykrywanie przepływu płynu
CN109688991B (zh) 2016-07-08 2021-10-29 康沃特克科技公司 柔性负压系统
FR3068975B1 (fr) * 2017-07-12 2020-07-17 Urgo Recherche Innovation Et Developpement Composition pour pansement interface
FR3068974B1 (fr) * 2017-07-12 2019-08-02 Urgo Recherche Innovation Et Developpement Pansement permettant la liberation controlee et prolongee d'actif
US12161792B2 (en) 2017-11-16 2024-12-10 Convatec Limited Fluid collection apparatus
CN108029925A (zh) * 2017-12-29 2018-05-15 常德金德新材料科技股份有限公司 一种基于短周期即食品的天然防霉材料及制备方法
CN109793919B (zh) * 2019-02-01 2022-01-14 明基材料（芜湖）有限公司 硫化氢缓释敷料及其制造方法
WO2020245656A1 (en) 2019-06-03 2020-12-10 Convatec Limited Methods and devices to disrupt and contain pathogens
US11331221B2 (en) 2019-12-27 2022-05-17 Convatec Limited Negative pressure wound dressing
US11771819B2 (en) 2019-12-27 2023-10-03 Convatec Limited Low profile filter devices suitable for use in negative pressure wound therapy systems

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2446793A (en) * 1945-07-04 1948-08-10 Wm S Merrell Co Substituted pyridinium and piperidinium compounds
US3929741A (en) * 1974-07-16 1975-12-30 Datascope Corp Hydrophilic acrylamido polymers
GB1576522A (en) 1977-05-24 1980-10-08 Colorplast International A S Sealing material for ostomy devices
DK147035C (da) 1980-12-05 1984-09-03 Coloplast As Hudplade
US4912093A (en) * 1986-10-01 1990-03-27 Marion Laboratories, Inc. Use of synthetic sulfated saccharides to enhance wound healing
DK154747C (da) 1986-10-17 1989-05-08 Coloplast As Bandage med en hudvenlig, vandabsorberende klaebeskive der paa den ene flade er fast forbundet med en ikke-klaebende daekfilm og paa den anden med et aftageligt beskyttelsesdaekke
DK154806C (da) 1986-12-19 1989-06-26 Coloplast As Saarplejemiddel indeholdende et aktivt stof til fremme af saarbehandlingen og fremgangsmaade til fremstilling deraf
US5681579A (en) * 1993-03-22 1997-10-28 E.R. Squibb & Sons, Inc. Polymeric support wound dressing
US5968001A (en) 1996-05-14 1999-10-19 Bristol-Myers Squibb Company Wound dressings with leak prevention seal
FR2753380B1 (fr) 1996-09-16 1998-12-04 Lhd Lab Hygiene Dietetique Nouvelle masse adhesive hydrophile
DE69934296T2 (de) 1998-01-16 2007-07-05 Société d'Exploitation de Produits pour les Industries Chimiques-Seppic Verdickend wirkendes latex, verfahren zu dessen herstellung und anwendungen in der kosmetik
FR2782086B1 (fr) * 1998-08-04 2000-12-01 Seppic Sa Nouveau latex epaississant a base d'acide 2-methyl 2-[(1-oxo 2-propenyl) amino] 1-propanesulfonique, copolymerise avec l'acrylate de (2-hydroxyethyle), procede de preparation et applications en cosmetique
FR2775903B1 (fr) 1998-03-12 2001-06-08 Lhd Lab Hygiene Dietetique Masse hydrocolloide a absorption accrue des les premieres heures d'utilisation
GB2341185A (en) 1998-09-07 2000-03-08 Polybiomed Ltd Polymerizable material and adhesive sheet material therefrom; dressings, electrodes and transdermal patches
FR2783412B1 (fr) * 1998-09-18 2000-12-15 Lhd Lab Hygiene Dietetique Compresse non adherente sterile
US5970515A (en) 1998-09-23 1999-10-26 Fishbaugh; Brenda B. Protective eyewear
US20020197302A1 (en) * 1998-11-12 2002-12-26 Cochrum Kent C. Hemostatic polymer useful for rapid blood coagulation and hemostasis
FR2806629B1 (fr) 2000-03-22 2003-01-24 Lhd Lab Hygiene Dietetique Compresse antiseptique
WO2002087645A1 (en) * 2001-05-01 2002-11-07 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions
JP2003300856A (ja) * 2002-04-05 2003-10-21 Fancl Corp 化粧料組成物
KR100529209B1 (ko) 2002-08-28 2005-11-17 한국과학기술연구원 세포 친화성이 향상된 생분해성의 조직 공학용 다공성고분자 지지체의 제조방법
WO2004103415A2 (en) * 2003-05-20 2004-12-02 Avery Dennison Corporation Multi-dressing system for managing skin wounds
US20060018852A1 (en) 2003-08-22 2006-01-26 L'oreal Compositions containing topical active agents and pentylene glycol
US20080064999A1 (en) 2004-07-16 2008-03-13 Kristian Larsen Wound Care Device
JP5102944B2 (ja) * 2005-06-08 2012-12-19 ロート製薬株式会社 皮膚外用剤
JP2009040685A (ja) * 2005-11-04 2009-02-26 Toagosei Co Ltd 貼付剤
US7851633B2 (en) * 2006-06-09 2010-12-14 Beiersdorf Ag Piperidinium compounds and cosmetic compositions containing them
FR2916355B1 (fr) 2007-05-25 2009-08-28 Urgo Soc Par Actions Simplifie Nouveau principe actif dans la cicatrisation et son utilisation

Also Published As

Publication number Publication date
PL2148703T3 (pl) 2011-06-30
PT2148703E (pt) 2010-12-14
EP2148703A1 (fr) 2010-02-03
AU2008259661B2 (en) 2013-05-09
EP2148703B1 (fr) 2010-09-29
DE602008002835D1 (de) 2010-11-11
FR2916356A1 (fr) 2008-11-28
BRPI0811948B1 (pt) 2018-07-17
BRPI0811948A2 (pt) 2014-10-14
US20100285129A1 (en) 2010-11-11
KR101445900B1 (ko) 2014-09-29
CA2687731C (fr) 2015-04-28
US10500301B2 (en) 2019-12-10
FR2916356B1 (fr) 2009-08-28
RU2009147169A (ru) 2011-06-27
CN101678146A (zh) 2010-03-24
MX2009012743A (es) 2010-03-15
HK1140972A1 (en) 2010-10-29
ATE482726T1 (de) 2010-10-15
JP2010527977A (ja) 2010-08-19
AU2008259661A1 (en) 2008-12-11
RU2448737C2 (ru) 2012-04-27
ES2353851T3 (es) 2011-03-07
JP5290277B2 (ja) 2013-09-18
WO2008149036A1 (fr) 2008-12-11
CA2687731A1 (fr) 2008-12-11
KR20100016275A (ko) 2010-02-12
CN101678146B (zh) 2012-11-21
DK2148703T3 (da) 2011-01-10

Similar Documents

Publication Publication Date Title
BRPI0811948B8 (pt) novo agente para a liberação de princípios ativos em curativos que contenham ao menos uma susbtância gordurosa
ES2524320T3 (es) Composición para la prevención o el tratamiento de enfermedad asociada con trombo o émbolo
CY1120888T1 (el) Διαδερμικες φαρμακευτικες συνθεσεις περιλαμβανοντας ενεργους παραγοντες
BR112013018352A2 (pt) composição de minociclina tópica e método
UY31209A1 (es) Uso de homo y copolimeros para la estabilización de formulaciones de principios activos
CL2008001756A1 (es) Agente de arn de interferencia (iarn); composicion farmaceutica que lo comprende; y su uso para tratar procesos patologicos mediados al menos en parte por la expresion del canal de sodio epitelial alfa (alfa-enac)
BRPI0609393B8 (pt) usos de um composto 11-desóxi-prostaglandina
BR112014002769A2 (pt) método e kit depilatório
CO6650415A2 (es) Nuevas formas de dosificacion de liberación modificada de un inhibidor de la xantina oxidorreductasa o de inhibidoes de xantina oxidasa
BR112012014260A2 (pt) composições de iodopovidona oftalmológica não irritante
EP4616907A3 (en) Soft tissue filler
CL2008000893A1 (es) Composición para el cuidado bucal que comprende una cantidad efectiva de un aminoácido básico y un agente antibacteriano; uso en el tratamiento antibacteriano de la cavidad bucal.
IN2012DN02817A (pt)
CL2011002964A1 (es) Composicion para controlar enfermedades de plantas que comprende acido 4-oxo-4-[(2-feniletilamino]-butirico y un inhibidor ajeno a quinona; agente de tratamiento de semillas; y uso.
MX2012006629A (es) Microorganismos probioticos como agentes activos contra cambios en microrelieve de la piel.
BR112013019394A2 (pt) uso de um agente
MX390493B (es) Composiciones que comprenden celulas germinales mesenquimales y usos de las mismas
BR112012007798A2 (pt) microcápsulas estáveis e composição para aplicação tópica e método para a preparação de microcápsulas
MX2009012742A (es) Ingrediente activo novedoso en cicatrizacion y uso del mismo.
CL2009001841A1 (es) Uso de una composición de liberación sostenida de 4-aminopiridina para preparar un medicamento útil para tratar esclerosis multiple en un sujeto.
BR112022026699A2 (pt) Mecanismo de liberação de fragrâncias, método e usos do mesmo
BR112012007842A2 (pt) um copolímero em bloco e composição de poliesteramida com terminação éster e usos dos mesmos
BR112014026483A2 (pt) composição antimicrobiana, composição antimicrobiana bicomponente, pano de limpeza, método para desinfetar uma superfície e método para controlar esporos sobre uma superfície
BRPI0600195A (pt) composição aquosa
MX353580B (es) Acido graso monoinsaturado para prevenir y/o tratar las imperfecciones del color de la piel.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/05/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2776 DE 19-03-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.